Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2012-005571-14-ES
EUCTR2012-005571-14-ES
Active, not recruiting
Phase 1

CLINICAL TRIAL, SINGLE BLIND, RANDOMIZED, CONTROLLED PROSPECTIVE EVALUATION FOR OPTIMUM TIME INTERVAL BETWEEN ACETATE ADMINISTRATION AND PUNCTURE TRIPTORELIN FOLLICULAR IN IVF TREATMENT

INSTITUTO DE INVESTIGACION SANITARIA LA FE0 sites176 target enrollmentJune 25, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsINFERTILITYTherapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
DrugsDECAPEPTYL

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
INFERTILITY
Sponsor
INSTITUTO DE INVESTIGACION SANITARIA LA FE
Enrollment
176
Status
Active, not recruiting
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 25, 2013
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
INSTITUTO DE INVESTIGACION SANITARIA LA FE

Eligibility Criteria

Inclusion Criteria

  • •Age less than or equal to 37 years. Sterility of tubal origin, unknown or treatable
  • •male factor IVF / ICSI using ejaculated semen (including frozen semen donor).
  • •Blood levels of basal FSH \<10 mIU / ml on day 3 of the menstrual cycle. Serum
  • •AMH\> 5 and \<45 pmol / l Number of antral follicles\> 6 and \<24 between both
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 176
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Diagnosis of endometriosis severe (Grade III\-IV). Diagnosis of SDM. polycystic
  • •ovaries (defined according to the Rotterdam criteria). History of low response in
  • •ovarian stimulation cycles prior defined as presence of less than 4 follicles greater
  • •than 16 mm or canceled cycle. All those patients who do not voluntarily give their
  • •express written consent Known allergy to the drug

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes.
PER-081-02FAMILY HEALTH INTERNATIONAL, HPTN CORE,
Active, not recruiting
Phase 1
CLINICAL TRIAL RANDOMIZED, DOUBLE-BLIND CONTROLLED, PHASE III, TO EVALUATE THE USE OF PLATELET RICH PLASMA IN FRONT HYALURONIC ACID IN COXARTHROSIS.coxarthrosisMedDRA version: 18.0Level: PTClassification code 10058417Term: Hyaluronic acidSystem Organ Class: 10022891 - InvestigationsTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
EUCTR2014-004120-21-ESFUNDACIÓN PÚBLICA ANDALUZA PROGRESO Y SALUD70
Active, not recruiting
Not Applicable
CLINICAL TRIAL OF LARVAL THERAPY IN PATIENTS WITH LEG ULCERSVenous or mixed venous/arterial ulcersTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
EUCTR2011-001284-44-HUMAGGOT 2006 Egészségügyi, Kereskedelmi és Szolgáltató Ltd.
Completed
Not Applicable
Study on different sensations between hands
CTRI/2022/08/044807World Pranic Healing Foundation India Research Centre108
Completed
Not Applicable
CLINICAL TRIAL, CROSS, RANDOMIZED, DOUBLE BLIND, CONTROLLED AGAINST PLACEBO USING VALACICLOVIR TO REMOVE THE EXCRETION OF SIMPLE HERP VIRUS (VHS) AND HUMAN IMMUNODEFICIENCY VIRUSES (HIV) IN INDIVIDUALS COINFECTED WITH HIV TYPE 1 AND VHS TYPE 2.
PER-082-02GLAXOSMITHKLINE RESEARCH TRIANGLE PARK,